KCNJ10杂合变异通过单倍剂量不足导致阵发性运动诱发性运动障碍
研究对106例PRRT2阴性PKD先证者行全外显子测序,在8个无关家系11例中检出KCNJ10杂合变异,占7.5%(8/106);HEK293T细胞显示钾电流降低,果蝇实验支持单倍剂量不足机制,提示KCNJ10杂合变异是PKD此前未识别的遗传病因,并涉及胶质细胞参与。
要点
- KCNJ10杂合变异见于7.5%(8/106)的PRRT2阴性PKD先证者。
- 患者均表现为突然运动诱发的肌张力障碍发作,持续时间短。
- HEK293T细胞显示患者来源变异钾电流明显降低,提示功能丧失。
核心结论
- KCNJ10杂合变异导致的单倍剂量不足可理解为PKD此前未识别的遗传病因,并提供胶质细胞参与PKD病理生理的证据。
研究设计与样本
- 对106例PRRT2阴性PKD先证者行全外显子测序,并在HEK293T细胞和果蝇中研究变异的功能影响。
主要发现
- 在8个无关家系的11例个体中检出KCNJ10杂合变异,占PRRT2阴性先证者的7.5%(8/106)。
- 变异共分离及PKD病例中罕见KCNJ10变异频率显著更高,支持检出的KCNJ10杂合变异对PKD发病的影响。
- 一个典型EAST/SeSAME家系中携带KCNJ10突变的父亲被识别为PKD患者。
- 所有患者均表现为突然运动诱发的肌张力障碍发作,发作持续时间短。
- HEK293T细胞膜片钳记录显示患者来源变异的K+电流明显降低,提示功能丧失;果蝇中杂合Irk2敲入蝇的高兴奋性表型较纯合子更轻,支持单倍剂量不足机制;Irk2单倍剂量不足蝇的兴奋性神经元兴奋性增加,胶质细胞特异性补充人Kir4.1可挽救Irk2突变表型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Most paroxysmal kinesigenic dyskinesia (PKD) cases are hereditary, yet approximately 60% of patients remain genetically undiagnosed. We undertook the present study to uncover the genetic basis for undiagnosed PKD patients. METHODS: Whole-exome sequencing was performed for 106 PRRT2-negative PKD probands. The functional impact of the genetic variants was investigated in HEK293T cells and Drosophila. RESULTS: Heterozygous variants in KCNJ10 were identified in 11 individuals from 8 unrelated families, which accounted for 7.5% (8/106) of the PRRT2-negative probands. Both co-segregation of the identified variants and the significantly higher frequency of rare KCNJ10 variants in PKD cases supported impacts from the detected KCNJ10 heterozygous variants on PKD pathogenesis. Moreover, a KCNJ10 mutation-carrying father from a typical EAST/SeSAME family was identified as a PKD patient. All patients manifested dystonia attacks triggered by sudden movement with a short episodic duration. Patch-clamp recordings in HEK293T cells revealed apparent reductions in K+ currents of the patient-derived variants, indicating a loss-of-function. In Drosophila, milder hyperexcitability phenotypes were observed in heterozygous Irk2 knock-in flies compared to homozygotes, supporting haploinsufficiency as the mechanism for the detected heterozygous variants. Electrophysiological recordings showed that excitatory neurons in Irk2 haploinsufficiency flies exhibited increased excitability, and glia-specific complementation with human Kir4.1 rescued the Irk2 mutant phenotypes. INTERPRETATION: Our study established haploinsufficiency resulting from heterozygous variants in KCNJ10 can be understood as a previously unrecognized genetic cause for PKD and provided evidence of glial involvement in the pathophysiology of PKD. ANN NEUROL 2024;96:758-773.
引用
- Li YL, Lin J, Huang X, et al. Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency. Ann Neurol. 2024. PMID: 38979912. doi:10.1002/ana.27018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。